Last reviewed · How we verify
Placebo for BG2109
A placebo control has no active pharmacological mechanism.
At a glance
| Generic name | Placebo for BG2109 |
|---|---|
| Sponsor | Bio Genuine (Shanghai) Biotech Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Placebos are inert substances used as controls in clinical trials to establish the efficacy of an active investigational drug (BG2109) through comparison. Any observed effects in the placebo arm are attributed to natural disease progression, regression to the mean, or psychological factors rather than direct drug action.
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |